Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

New non-invasive quality assurance method developed by Dr. Bruce Yu and his team offers more effective way to detect freezing events in vaccines at the point-of-care.

Peter Swaan, PhD, succeeds Paul Shapiro, PhD, as chair of the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy.

Ralph Blomster, PhD, is remembered for his more than 40 years of service to the School.

Biennial event facilitates scientific exchange and interactive communication among students, postdoctoral fellows, and faculty from two of Baltimore’s premier academic institutions.

Event organized by the School’s Metallotherapeutics Research Center brings together regional experts with interest in metal systems to stimulate interaction and collaboration.

Day-long event provides glimpses into potential careers for students and allows alumni to reconnect with faculty and one another.

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation brings together more than 600 researchers from academia, government, and industry.

More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation addressed current knowledge gaps in the dissolution similarity evaluation of pharmaceutical products.